Ocular pharmacokinetics/pharmacodynamics

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 44, Issue 1, 1997, Pages 71-83

  Worakul, Nimit ^a   Robinson, Joseph R ^b  

^a Faculty of Pharmaceutical Sciences   (Thailand)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Compartment; Drug delivery system; Human; Model; Ocular; Ophthalmic; Pharmacodynamics; Pharmacokinetics; Rabbit; Review

Indexed keywords

BUPRANOLOL; CHOLINERGIC RECEPTOR STIMULATING AGENT; FLUOROMETHOLONE; IBUFENAC; IBUPROFEN; PILOCARPINE; TIMOLOL;

ANTERIOR EYE CHAMBER; COMPARTMENT MODEL; CORNEA THICKNESS; DOSE TIME EFFECT RELATION; DRUG ABSORPTION; DRUG DELIVERY SYSTEM; DRUG DISPOSITION; DRUG PENETRATION; DRUG RETENTION; EYE; HUMAN; INTRAOCULAR PRESSURE; LIPID SOLUBILITY; MIOSIS; MYDRIASIS; NONHUMAN; PUPIL REFLEX; RABBIT; REVIEW; TEAR FILM; TOPICAL DRUG ADMINISTRATION;

EID: 0031395197     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(97)00064-7     Document Type: Review

References (71)

1. J.C. Fleishaker, J.J. Ferry. Pharmacokinetic-pharmacodynamic modeling in drug development: Concepts and applications, in: H. Derendorf, G. Hochhaus (Eds.), Handbook of Pharmacokinetic/ Pharmacodynamic Correlation, CRC Press, Boca Raton, FL, 1995, pp. 57-78.
2. J.J. Lima, Pharmacokinetics and pharmacodynamics, in: J. Swarbrick, J.C. Boylan (Eds.), Encyclopedia of Pharmaceutical Technology, Vol 12, Marcel Dekker, New York, 1995, pp. 29-52.
3. N.H. Holford, L.B. Scheiner, Kinetics of pharmacologic response, in: M. Rowland, G. Tucker (Eds.), Pharmacokinetics: theory and methodology, Pergamon press, 1986, pp. 189-212.
4. G. Hecht, Ophthalmic preparations, in: A.R. Gennaro, (Ed.), Remington: The Science and Practice of Pharmacy., 19th Edn. vol II, Mack, PA, 1995, pp. 1563-1576.
5. I.K. Reddy, M.G. Ganesan, Ocular therapeutics and drug delivery: An Overview, in: I.K. Reddy (Ed.), Ocular Therapeutics and Drug Delivery: A Multi-Disciplinary Approach, Technomic Publishing Co., Inc., Lancaster, Pennsylvania, USA, 1996, pp. 3-29.
6. S. Nagataki, S. Mishima, Pharmacokinetics of instilled drugs in the human eye. Int. Ophthalmol. Clin. 20 (3) (1980) 33-49.
7. R. Garny, Preliminary study of prolonged acting drug delivery system for the treatment of glaucoma. Pharm. Acta. Helv. 56 (1981) 130-132.
8. R.A. Lewis, R.D. Schoenwald, C.F. Barfknecht, C.D. Phelps, Aminozolamide gel: A trial of a topical carboic anhydrase inhibitor in ocular hypertension. Arch. Ophthalmol. 104 (1986) 842-844.
9. S. Miyazaki, K. Ishii, M. Takada, Use of fibrin film as a carrier for drug delivery: A long-acting delivery system for pilocarpine into the eye. Chem. Pharm. Bull. 30 (1982) 3405-3407.
10. P. Berthe, C. Baudouin, R. Garraffo, P. Hoffmann, A-M. Taburet, P. Lapalus, Toxicologic and pharmacokinetic analysis of intravitreal injections of Foscarnet, either alone or in combination with Ganciclovir. Invest. Ophthalmol. Vis. Sci. 35 (3) (1994) 1038-1045.
11. M. Barza, B. Doft, E. Lynch, Ocular penetration of ceftriazone, ceftazidime, and vancomycin after subconjunctival injection in humans. Arch. Ophthalmol. 111 (1993) 492-494.
12. J.A. Kelly, P.D. Molyneux, S.A. Smith, S.E. Smith, Relative bioavailability of pilocarpine from a novel ophthalmic delivery system and conventional eyedrop formulations. Br. J. Ophthalmol. 73 (1989) 360-362.
13. M.L. Friedberg, U. Pleyer, B.J. Mondino, Device drug delivery to the eye: Collagen shields, iontophoresis and pumps. Ophthalmology 98 (5) (1991) 725-732.
14. G.M. Grass, J. Cobby, M.C. Makoid, Ocular delivery of pilocarpine from erodible matrices. J. Pharm. Sci. 73 (1984) 618-621.
15. V.H-L. Lee, J.R. Robinson, Review: Topical ocular drug delivery: Recent developments and future challenges. J. Ocul. Pharmacol. 2 (1) (1986) 67-108.
16. K. Jarvinen, T. Jarvinen, A. Urtti, Ocular absorption following topical delivery. Adv. Drug. Deliv. Rev. 16 (1995) 3-19.
17. D.M. Maurice, S. Mashima, Ocular pharmacokinetics, in: M.L. Sear (Ed.), Handbook of Experimental Pharmacology: Pharmacology of the Eye, Springer-Verlag, New York, 69, 1984, pp. 19-116.
18. S. Mishima, Clinical pharmacokinetics of the eye. Invest. Ophthalmol. Vis. Sci. 21 (4) (1981) 504-541.
19. J.P. Frangie, Clinical pharmacokinetics of various topical ophthalmic delivery systems. Clin. Pharmacokinet. 29 (2) (1995) 130-138.
20. R.D. Schoenwald, Ocular pharmacokinetic/pharmacodynamic, in: A.K. Mitra (Ed.), Ophthalmic Drug Delivery System, Marcel Dekker, New York, 1993, pp. 83-110.
21. R.D. Schoenwald, Pharmacokinetics in ocular drug delivery, in: P. Edman (Ed.), Biopharmaceutics of Ocular Drug Delivery, CRC Press, Bato Raton FL, 1993, pp. 159-191.
22. R.D. Schoenwald, Ocular drug delivery: Pharmacokinetic considerations. Clin. Pharmacokinet. 18 (4) (1990) 255-269.
23. A. Urtti, L. Salminen, Minimizing systemic absorption of topically administered ophthalmic drugs. Sur. Ophthalmol. 37 (6) (1993) 435-456.
24. V.H-L. Lee, J.R. Robinson, Mechanistic and quantitative evaluation of precorneal pilocarpine disposition in Albino rabbits. J. Pharm. Sci. 68 (6) (1979) 673-684.
25. I. Ahmed, T.F. Patton, Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption. Int. J. Pharm. 38 (1987) 9-21.
26. D.S. Chien, J.J. Homsy, C. Gluchoeski, D.D. Tang-Liu, Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes. Curr. Eye. Res. 9 (11) (1990) 1051-1059.
27. M.C. Makoid, J.R. Robinson, Pharmacokinetics of topically applied pilocarpine in the Albino rabbit eye. J. Pharm. Sci. 68 (4) (1979) 435-443.
28. K.J. Himmelstein, I. Guvenir, T.F. Patton, Preliminary pharmacokinetic model of pilocarpine uptake and distribution in the eye. J. Pharm. Sci. 67 (5) (1978) 603-606.
29. R.F. Jones, D.M. Maurice, New methods of measuring the rate of aqueous flow in man with fluorescein. Exp. Eye. Res. 5 (1966) 208-220.
30. M.C. Makoid, J.W. Sieg, J.R. Robinson, Corneal drug absorption: An illustration of parallel first-order absorption and rapid loss of drug from absorption depot. J. Pharm. Sci. 65 (1) (1976) 150-152.
31. G.C-Y. Chiou, Y-Q. Zheng, Permeation enhancement for ocular route of polypeptide administration, in: D. Hsieh (Ed.), Drug Permeation Enhancement: Theory and Applications, Marcel Dekker, New York, 1994, pp. 385-395.
32. J.W. Sieg, J.R. Robinson, Mechanistic studies on transcorneal penetration of pilocarpine. J. Pharm. Sci. 65 (12) (1976) 1816-1822.
33. J.W. Sieg, J.R. Robinson, Mechanistic studies on transcorneal penetration of fluorometholone. J. Pharm. Sci. 70 (9) (1981) 1026-1029.
34. M.G. Eller, R.D. Schoenwald, J.A. Dixson, T. Segarra, C.F. Barfknecht, Topical carbonic anhydrase inhibitors IV: Relationship between excised corneal permeability and pharmacokinetic factors. J. Pharm. Sci. 74 (5) (1985) 525-529.
35. C.S. Rao, R.D. Schoenwald, C.F. Barfknecht, S.L. Laban, Biopharmaceutical evaluation of ibufenac, ibuprofen, and their hydroxyethoxy analogs in the rabbit eye. J. Pharmacokinet. Biopharm. 20 (4) (1992) 357-387.
36. T.F. Patton, Ocular drug disposition, in: J.R. Robinson, (Ed.), Ophthalmic Drug Delivery Systems, American Pharmaceutical Association, 1980, pp. 28-54.
37. S.C. Miller, K.J. Himmelstein, T.F. Patton, A physiologically based pharmacokinetic model for the intraocular distribution of pilocarpine in rabbits. J. Pharmacokinet. Biopharm. 9 (6) (1981) 653-677.
38. C. Oh, B.A. Saville, Y-L. Cheng, D.S. Rootman, A compartment model for the ocular pharmacokinetics of cyclosporine in rabbits. Pharm. Res. 12 (3) (1995) 433-437.
39. I. Ahmed, R.D. Gokhale, M.V. Shah, T.F. Patton, Physicochemical determinants of drug diffusion across the conjunctiva, sclera and cornea. J. Pharm. Sci. 76 (8) (1987) 583-586.
40. R.D. Schoenwald, G. Deshpande, D.G. Rethwisch, C.F. Barfknecht, Penetration into the anterior chamber via the conjunctival/scleral pathway. J. Ocul. Pharmacol. Therapeutics 13 (1) (1997) 41-59.
41. A. Ohtori, K. Tojo, In vivo/in vitro correlation of intravitreal delivery of drugs with the help of computer simulation. Biol. Pharm. Bull. 17 (20) (1994) 283-290.
42. I. Zaki, P. Fitzgerald, J.G. Hardy, C.G. Wilson, A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man. J. Pharm. Pharmacol. 38 (6) (1986) 463-466.
43. A. Urtti, L. Salminen, Animal pharmacokinetic studies, in: A.K. Mitra, (Ed.), Ophthalmic Drug Delivery System, Marcel Dekker, New York, 1993 pp. 121-136.
44. D.M. Maurice, Prolonged-action drops. Int. Ophthal. Clin. 33 (4) (1993) 81-91.
45. M.F. Saettone, B. Giannaccini, F. Barattini, N. Tellini, The validity of rabbits for investigations on ophthalmic vehicles: A comparison of four different vehicles containing tropicamide in humans and rabbits. Pharm. Acta. Helv. 57 (2) (1982) 47-55.
46. S.S. Chrai, T.F. Patton, A. Mehta, J.R. Robinson, Lacrimal and instilled fluid dynamics in rabbit eyes. J. Pharm. Sci. 62 (7) (1973) 1112-1121.
47. L.G. Carney, R.M. Hill, Human tear buffering capacity. Arch. Ophthalmol. 97 (5) (1979) 951-952.
48. O. Olejnik, Conventional systems in ophthalmic drug delivery, in: A.K. Mitra, (Ed.), Ophthalmic Drug Delivery System, Marcel Dekker, New York, 1993, pp. 177-198.
49. J. Stjernschantz, M. Astin, Anatomy and physiology of the eye, Physiological aspects of ocular drug therapy, in: P. Edman (Ed.), Biopharmaceutics of Ocular Drug Delivery, CRC Press, Boca Raton, FL, 1993, pp. 1-25.
50. M.A. Watsky, M. Jablonski, H.F. Edelhauser, Comparison of conjunctival and corneal surface areas in rabbit and human. Curr. Eye. Res. 7 (5) (1988) 483-486.
51. J.M. Conrad, J.R. Robinson, Aqueous chamber distribution volume measurement in rabbits. J. Pharm. Sci. 66 (2) (1977) 219-224.
52. C.M. Hutak, R.B. Jacaruso, Evaluation of primary ocular irritation: Alternatives to the Draize test, in: I.K. Reddy (Ed.), Ocular Therapeutics and Drug Delivery: A Multidisciplinary Approach, Technomic Publishing Co., Inc., Lancaster, Pennsylvania, USA, 1996, pp. 489-525.
53. D.M. Maurice, The effect of the low blink rate in rabbits on topical drug penetration. J. Ocul. Pharmacol. Therapeutics, 11 (3) (1995) 297-304.
54. L. Soldati, V. Gianesello, I. Galbiati, A. Gazzaniga, M. Virno, Ocular pharmacokinetics and pharmacodynamics in rabbits of ibopamine, a new mydriatic agent. Exp. Eye. Res. 56 (1993) 247-254.
55. D-S. Chein, R.D. Schoenwald, Ocular pharmacokinetics and pharmacodynamics of phenylephrine and phenylephrine oxazolidine in rabbit eyes, Pharm. Res. 7 (5) (1990) 476-483.
56. S.E. Smith, Dose-response relationships in tropicamide-induced mydriasis and cycloplegia. Br. J. Clin. Pharmacol. 1 (1974) 37-40.
57. M.C. Richardson, P.M. Bentley, A new ophthalmic delivery system, in: A.K. Mitra (Ed.), Ophthalmic Drug Delivery System, Marcel Dekker, New York, 1993, pp. 355-367.
58. M.L. Putnam, R.D. Schoenwald, M.W. Duffel, C.F. Barfknecht, T.M. Segarra, D.A. Campbell, Ocular disposition of aminozolamide in the rabbit eye. Invest. Ophthalmol. Vis. Sci. 28 (8) (1987) 1373-1382.
59. V.H-L. Lee, A.M. Luo, S. Li, S.K. Podder, J.S-C. Chang, S. Ohdo, G.M. Grass, Pharmacokinetic basis for nonadditivity of intraocular pressure lowering in timolol combinations. Invest. Ophthalmol. Vis. Sci. 32 (11) (1991) 2948-2957.
60. A. Urtti, H. Rouhiainen, T. Kaila, V. Saano, Controlled ocular timolol delivery: Systemic absorption and intraocular pressure effects in humans. Pharm. Res. 11 (9) (1994) 1278-1282.
61. W.F. Brechue, T.H. Maren, pH and drug ionization affects ocular pressure lowering of topical carbonic anhydrase inhibitors. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2581-2587.
62. M. Sharir, W.M. Pierce, (Jr.), D. Chen, T.J. Zimmerman, Pharmacokinetics, acid-base balance and intraocular pressure effects of ethyloxaloylazolamide: A novel topically active carbonic an-hydrase inhibitor. Exp. Eye. Res. 58 (1994) 107-116.
63. J. Kreuter, Particulates nanoparticles and microparticles, in: A.K. Mitra (Ed.), Ophthalmic Drug Delivery System, Marcel Dekker, New York, 1993, pp. 275-287.
64. A. Zimmer, Pharmacokinetics and Pharmacodynamics of Pilocarpine-loaded PBCA nanoparticles in the glaucomatous rabbit eye. PhD Thesis, JWG University of Frankfurt, Germany, 1993.
65. D.D-S. Tang-Liu, A. Acheampong, D-S. Chien, J.I. Usansky, Pharmacokinetic and Pharmacodynamic correlation of ophthalmic drugs, in: I.K. Reddy (Ed.), Ocular therapeutics and drug delivery: A Multi-Disciplinary Approach, Technomic Publishing Co., Inc., Lancaster, Pennsylvania, USA, 1996, 133-147.
66. S.W. Friedrich, Y-L. Cheng, B.A. Saville, Theoretical corneal permeation model for ionizable drugs. J. Ocul. Pharmacol. 9 (3) (1993) 229-249.
67. S. Friendrich, B.A. Saville, Y-L. Cheng, D.S. Rootman, Pharmacokinetic differences between ocular inserts and eyedrops. J. Ocul. Pharmacol. Therapeutics 12 (1) (1996) 5-18.
68. A. Zimmer, J. Kreuter, J.R. Robinson, Studies on transport pathway of PBCA nanoparticles in ocular tissues. J. Microen-capsulation, 8 (4) (1991) 497-504.
69. I. Ahmed, T.F. Patton, Importance of the noncorneal absorption route in topical ophthalmic drug delivery. Invest. Ophthalmol. Vis. Sci. 26 (4) (1985) 584-587.
70. T.J. Mikkelson, Ophthalmic drug delivery. Pharm. Tech. (1984) 90-98.
71. G.M. Grass, V.H-L. Lee, A model to predict aqueous humor and plasma pharmacokinetics of ocular applied drugs. Invest. Ophthalmol. Vis. Sci. 34 (7) (1993) 2251-2259.